A case of hereditary angioedema due to C1-inhibitor deficiency with recurrent abdominal pain diagnosed 40 years after the occurrence of the initial symptom

Clin J Gastroenterol. 2021 Aug;14(4):1175-1179. doi: 10.1007/s12328-021-01338-1. Epub 2021 Feb 5.

Abstract

Hereditary angioedema due to C1-inhibitor deficiency (HAE-C1-INH) is a rare disease, which induces an acute attack of angioedema mediated by bradykinin. HAE-C1-INH can cause serious abdominal pain when severe edema develops in the gastrointestinal tract. However, because it takes a long time, 13.8 years on average in Japan, from the occurrence of the initial symptom to the diagnosis due to low awareness of the disease, undiagnosed HAE-C1-INH patients sometimes undergo unnecessary surgical procedures for severe abdominal pain. We herein present a 56-year-old patient with HAE-C1-INH, who underwent numerous abdominal operations. He frequently needed hospitalization with the administration of opioid due to severe abdominal pain. However, after he was accurately diagnosed with HAE-C1-INH at 55 years of age, he could start self-administration for an acute attack with icatibant, a selective bradykinin B2 receptor antagonist. Consequently, he did not need hospitalizing for ten months after the beginning of the treatment. A series of an accurate diagnosis and appropriate treatment for HAE-C1-INH improved his quality of life. Thus, HAE-C1-INH should be considered, when we meet patients with unidentified recurrent abdominal pain. This case highlights significance of an early diagnosis and appropriate treatment for HAE-C1-INH.

Keywords: Abdominal pain; Bradykinin; C1-inhibitor; Hereditary angioedema; Icatibant.

Publication types

  • Case Reports

MeSH terms

  • Abdominal Pain / etiology
  • Angioedemas, Hereditary* / complications
  • Angioedemas, Hereditary* / diagnosis
  • Complement C1 Inhibitor Protein
  • Humans
  • Japan
  • Male
  • Middle Aged
  • Quality of Life

Substances

  • Complement C1 Inhibitor Protein